ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 293,74
-0,94%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Karuna Therapeutics Inc (KRTX)

  7. Karuna Therapeutics Inc (KRTX) Actualités

KRTX Karuna Therapeutics Inc

329,83
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Karuna Therapeutics Inc KRTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 329,83 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
329,83 329,83
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:01EDGAR2Form 144 - Report of proposed sale of securities
01/3/202412:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/3/202412:01EDGAR2Form 8-K - Current report
22/2/202412:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202412:32EDGAR2Form 8-K - Current report
22/2/202412:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
15/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202417:56EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/1/202412:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
16/1/202422:18EDGAR2Form 8-K - Current report
09/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
08/1/202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
29/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202323:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202323:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202323:07EDGAR2Form 8-K - Current report
22/12/202322:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202322:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202322:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202321:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
22/12/202317:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
22/12/202314:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202314:26EDGAR2Form 8-K - Current report
22/12/202314:02DJFRBristol Myers Squibb va acquérir Karuna Therapeutics pour 14..
22/12/202313:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
22/12/202312:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
15/12/202300:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
12/12/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202321:24EDGAR2Form 144 - Report of proposed sale of securities
29/11/202316:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
29/11/202313:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
29/11/202312:30BWKaruna Therapeutics Announces U.S. Food and Drug..
16/11/202322:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
13/11/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:25EDGAR2Form 144 - Report of proposed sale of securities
02/11/202311:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202311:36EDGAR2Form 8-K - Current report
02/11/202311:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
01/11/202311:45BWKaruna Therapeutics to Present Data from the EMERGENT..
01/11/202311:30BWKaruna Therapeutics to Present at Upcoming Investor..
19/10/202312:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
KRTX
Karuna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés